Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

U-Screen Dx

U-Screen Dx
2013 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Grant LATEST DEAL TYPE
$252K LATEST DEAL AMOUNT
3 INVESTORS
Description

Developer of cancer screening tests. The company is an early stage bio-tech enterprise developing screening tests focused on infection-related cancers such as hepatitis B virus (HBV)-induced liver cancer.

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Other Healthcare Technology Systems
Other Industries
Discovery Tools (Healthcare)
Biotechnology
Primary Office
  • 3805 Old Easton Road
  • Doylestown, PA 18902
  • United States

+1 (484) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore U-Screen Dx’s full profile, request a free trial.

U-Screen Dx Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Grant 01-Jan-2015 $252K Completed Startup
1. Accelerator/Incubator 11-Jul-2014 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

U-Screen Dx Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
National Institutes of Health Government 000 0000 000000 0
U.S. Department of Health and Human Services Government 000 0000 000000 0
Founder.org Accelerator/Incubator Minority 000 0000 000000 0

U-Screen Dx Executive Team (3)

Name Title Board
Seat
Contact
Info
Selena Lin Ph.D Chief Executive Officer & Co-Founder
Frank Song Ph.D President & Co-Founder
Ali Sajwani Chief Financial Officer